A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: A report of three cases [3]

British Journal of Haematology

Volumn 139, Issue 1, 2007, Pages 164-165

  Parnes, Aric ^a   Bifulco, Carlo ^a   Vanasse, Gary J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lymphoblastic leukaemia; Adult; Alemtuzumab; Fludarabine; Refractory

Indexed keywords

ALEMTUZUMAB; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; BACTEREMIA; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CASE REPORT; DISEASE COURSE; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; TREATMENT OUTCOME; VIDARABINE;

EID: 34548552990     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06760.x     Document Type: Letter

References (7)

1. Aguayo, A., Cortes, J., Thomas, D., Pierce, S., Keating, M. Kantarjian, H. (1999) Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia. Cancer, 86, 1203 1209.
2. Golay, J., Cortiana, C., Manganini, M., Cazzaniga, G., Salvi, A., Spinelli, O., Bassan, R., Barbui, T., Biondi, A., Rambaldi, A. Introna, M. (2006) The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis. Haematologica, 91, 322 330.
3. Kantarjian, H.M., O'Brien, S., Smith, T.L., Cortes, J., Giles, F.J., Beran, M., Pierce, S., Huh, Y., Andreeff, M., Koller, C., Ha, C.S., Keating, M.J., Murphy, S. Freireich, E.J. (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. Journal of Clinical Oncology, 18, 547 561.
4. Laporte, J.P., Snard, F., Garderet, L., Fouillard, L. Gorin, N.C. (2004) Remission of adult acute lymphocytic leukaemia with alemtuzumab. Leukemia, 18, 1557 1558.
5. Larson, R.A., Dodge, R.K., Linker, C.A., Stone, R.M., Powell, B.L., Lee, E.J., Schulman, P., Davey, F.R., Frankel, S.R., Bloomfield, C.D., George, S.L. Schiffer, C.A. (1998) A randomized controlled trial of filgastrim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia. CALGB study 9111. Blood, 92, 1556 1564.
6. Piccaluga, P.P., Martinelli, G., Malagola, M., Rondoni, M., Bianchini, M., Vigna, E., Bosi, C., Gaitani, S., Visani, G. Baccarani, M. (2004) Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation. Leukemia Lymphoma, 45, 731 733.
7. Tibes, R., Keating, M.J., Ferrajoli, A., Wierda, W., Ravandi, F., Garcia-Manero, G., O'Brien, S., Cortes, J., Verstovsek, S., Browning, M.L. Faderl, S. (2006) Activity of alemtuzumab in patients with CD52-positive acute leukemia. Cancer, 106, 2645 2651.